Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Loh Evan
Relationship:  
City:   Boston
State:   MA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   16,163    

Indirect Shares

  0      
Direct Value   $139,816    

Indirect Value

  $0      
Total Shares   16,163      
Total Value   $139,816      


Alpine Immune Sciences Inc
 $139,816 Celladon Corp
 $0 Alpine Immune Sciences Inc
 $139,816 Celladon Corp
 $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    2    

     Stock price went up :

    0   
    2    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   2.0   
     Percentage Gain/Loss :
     0.0%
 52.3%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Paratek Pharmaceuticals Inc PRTK CEO, Director 2023-09-21 0 2014-10-30 0    Premium*  
            Alpine Immune Sciences Inc ALPN Director 2015-06-16 2,163 0    Premium*  
            Celladon Corp CLDN 2022-03-11 14,000 2020-03-12 0    Premium*  
* Premium Members only  

Records found :    59         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
CLDN Celladon Corp   •       •      –    2022-03-11 4 A $0.00 $0 D/D 6,000 14,000 0 -
PRTK Paratek Pharmaceuticals I... CEO   •       •      –    2019-10-03 4 AS $3.98 $64,735 D/D (16,265) 413,935 0 -
PRTK Paratek Pharmaceuticals I... CEO   •       •      –    2019-10-04 4 A $0.00 $0 D/D 26,000 439,935 0 -
PRTK Paratek Pharmaceuticals I... CEO   •       •      –    2019-10-08 4 AS $3.82 $29,865 D/D (7,818) 432,117 0 -
PRTK Paratek Pharmaceuticals I... CEO   •       •      –    2019-12-12 4 S $3.10 $44,993 D/D (14,514) 417,603 0 -
PRTK Paratek Pharmaceuticals I... CEO   •       •      –    2020-02-19 4 A $0.00 $0 D/D 144,000 561,603 0 -
PRTK Paratek Pharmaceuticals I... CEO   •       •      –    2020-05-12 4 S $4.75 $45,576 D/D (9,595) 552,008 0 %
PRTK Paratek Pharmaceuticals I... CEO   •       •      –    2020-10-29 4 OE $4.30 $169,760 D/D 39,479 591,487 0 -
PRTK Paratek Pharmaceuticals I... CEO   •       •      –    2020-11-12 4 A $0.00 $0 D/D 75,000 666,487 0 -
PRTK Paratek Pharmaceuticals I... CEO   •       •      –    2020-11-13 4 AS $5.93 $124,103 D/D (20,928) 645,559 0 %
PRTK Paratek Pharmaceuticals I... CEO   •       •      –    2020-12-11 4 AS $6.95 $129,166 D/D (18,585) 626,974 0 %
PRTK Paratek Pharmaceuticals I... CEO   •       •      –    2020-12-14 4 AS $6.71 $177,245 D/D (26,415) 600,559 0 %
PRTK Paratek Pharmaceuticals I... CEO   •       •      –    2021-03-30 4 A $0.00 $0 D/D 303,750 904,309 0 -
PRTK Paratek Pharmaceuticals I... CEO   •       •      –    2021-05-27 4 A $0.00 $0 D/D 91,636 995,945 0 -
PRTK Paratek Pharmaceuticals I... CEO   •       •      –    2021-06-04 4 AS $9.70 $355,544 D/D (36,654) 959,291 0 %
PRTK Paratek Pharmaceuticals I... CEO   •       •      –    2021-08-16 4 A $0.00 $0 D/D 75,000 1,034,291 0 -
PRTK Paratek Pharmaceuticals I... CEO   •       •      –    2021-08-17 4 AS $5.12 $173,727 D/D (33,931) 1,000,360 0 %
PRTK Paratek Pharmaceuticals I... CEO   •       •      –    2021-12-13 4 AS $4.42 $61,805 D/D (13,983) 986,377 0 %
PRTK Paratek Pharmaceuticals I... CEO   •       •      –    2021-12-14 4 AS $4.37 $104,155 D/D (23,834) 962,543 0 %
PRTK Paratek Pharmaceuticals I... CEO   •       •      –    2021-12-15 4 AS $4.27 $210,336 D/D (49,259) 913,284 0 %
PRTK Paratek Pharmaceuticals I... CEO   •       •      –    2022-03-15 4 A $0.00 $0 D/D 236,250 1,149,534 0 -
PRTK Paratek Pharmaceuticals I... CEO   •       •      –    2022-08-08 4 A $0.00 $0 D/D 152,727 1,302,261 0 -
PRTK Paratek Pharmaceuticals I... CEO   •       •      –    2022-08-09 4 AS $2.66 $118,421 D/D (44,519) 1,257,742 0 %
PRTK Paratek Pharmaceuticals I... CEO   •       •      –    2022-10-25 4 A $0.00 $0 D/D 30,000 1,287,742 0 -
PRTK Paratek Pharmaceuticals I... CEO   •       •      –    2022-10-28 4 AS $3.47 $30,553 D/D (8,805) 1,278,937 0 %

  59  Records found
  1  2   3      
  Page 1 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed